Literature DB >> 20545944

Complement driven innate immune response to malaria: fuelling severe malarial diseases.

Karlee L Silver1, Sarah J Higgins, Chloe R McDonald, Kevin C Kain.   

Abstract

Severe malaria remains a major cause of global mortality. The innate immune response to infection is a key determinant of malaria severity and outcome. The complement system plays a key role in initiating and augmenting innate immune responses, including inflammation, endothelial activation, opsonization and coagulation, processes which have been implicated in malaria pathogenesis. In this review, we discuss the evidence supporting a role for excessive complement activation in the pathogenesis of severe malaria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545944     DOI: 10.1111/j.1462-5822.2010.01492.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  30 in total

1.  Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Xianzhen Hu; Oliver Billker; Julian C Rayner; Malika Ahras; Jillian E Wohler; Scott R Barnum
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

Review 2.  Innate immunity to malaria-The role of monocytes.

Authors:  Katherine R Dobbs; Juliet N Crabtree; Arlene E Dent
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

3.  Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.

Authors:  Ivo M B Francischetti; Carlo J Oliveira; Graciela R Ostera; Stephanie B Yager; Françoise Debierre-Grockiego; Vanessa Carregaro; Giovanna Jaramillo-Gutierrez; Jen C C Hume; Lubin Jiang; Samuel E Moretz; Christina K Lin; José M C Ribeiro; Carole A Long; Brandi K Vickers; Ralph T Schwarz; Karl B Seydel; Massimo Iacobelli; Hans C Ackerman; Prakash Srinivasan; Regis B Gomes; Xunde Wang; Robson Q Monteiro; Michail Kotsyfakis; Anderson Sá-Nunes; Michael Waisberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

4.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

5.  Monocyte dysregulation and systemic inflammation during pediatric falciparum malaria.

Authors:  Katherine R Dobbs; Paula Embury; John Vulule; Peter S Odada; Bruce A Rosa; Makedonka Mitreva; James W Kazura; Arlene E Dent
Journal:  JCI Insight       Date:  2017-09-21

Review 6.  Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question.

Authors:  Thiago Castro-Gomes; Luiza C Mourão; Gisely C Melo; Wuelton M Monteiro; Marcus V G Lacerda; Érika M Braga
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

Review 7.  A bite to fight: front-line innate immune defenses against malaria parasites.

Authors:  Stephanie Tannous; Esther Ghanem
Journal:  Pathog Glob Health       Date:  2018-01-29       Impact factor: 2.894

8.  Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.

Authors:  Hani Kim; Laura K Erdman; Ziyue Lu; Lena Serghides; Kathleen Zhong; Aggrey Dhabangi; Charles Musoke; Craig Gerard; Christine Cserti-Gazdewich; W Conrad Liles; Kevin C Kain
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

9.  Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.

Authors:  Arunaditya Deshmukh; Bishwanath Kumar Chourasia; Sonali Mehrotra; Ikhlaq Hussain Kana; Gourab Paul; Ashutosh Panda; Inderjeet Kaur; Susheel Kumar Singh; Sumit Rathore; Aparup Das; Priya Gupta; Md Kalamuddin; S K Gakhar; Asif Mohmmed; Michael Theisen; Pawan Malhotra
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

10.  Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia.

Authors:  Margaret A Lindorfer; Erika M Cook; Edimara S Reis; Daniel Ricklin; Antonio M Risitano; John D Lambris; Ronald P Taylor
Journal:  Clin Immunol       Date:  2016-08-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.